Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
APC down-regulated 1 like (APCDD1L) is a membrane-associated protein that is closely related to APCDD1, a negative regulator of Wnt and BMP signaling pathways[1][2]. APCDD1L is annotated as a protein-coding gene, with a structure and function inferred from its homology to APCDD1, which is known for playing a key role in embryonic development, nervous system patterning, and hair follicle cycling by inhibiting Wnt and BMP signaling through direct ligand sequestration or receptor binding[1][2][3]. The canonical gene symbol is **APCDD1L**, and it is sometimes listed as FLJ90166 or protein APCDD1-like. Although the direct involvement of APCDD1L as a therapeutic target has not been well-established in the primary literature, recent studies have examined the related lncRNA APCDD1L-AS1 in cancer[4]. No approved drugs currently target APCDD1L, and there is no evidence for its clinical use as a biomarker or safety concerns. The main biological role appears to be regulatory in signaling cascades central to development and cell fate. **Note:** - Most functional and disease data refer to APCDD1, with APCDD1L presumed to share some features based on high sequence homology and nomenclature. If information strictly specific to "APCDD1L" is required, experimental confirmation is limited; most publications and annotations are based on similarity to APCDD1[3]. - No drug interactions, mechanism of action for therapeutics, or safety concerns specific to APCDD1L have been reported in the reviewed literature. **If direct data for APCDD1L is later found, update: - molecular_classifications with any more specific function (e.g., Wnt pathway inhibitor, membrane protein, etc.) - is_target to true if therapeutic targeting evidence emerges**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on APC down-regulated 1 like (APCDD1L).